Keiretsu Capital

Keiretsu Capital, founded in 2013 and headquartered in Seattle with an additional office in San Francisco, operates as a private equity firm specializing in early-stage venture capital. The firm focuses on providing access to proprietary deal flow for its investors, enhancing the value of investments made by members of the Keiretsu Forum. By leveraging the world’s largest angel investor network, Keiretsu Forum, along with other prominent angel groups, Keiretsu Capital aims to achieve significant capital appreciation through investments in high-quality emerging companies. The firm strategically targets sectors such as life sciences, healthcare, technology, and real estate, with a particular emphasis on healthcare devices, information technology, and telecommunications. Through its various co-investment funds, Keiretsu Capital seeks to facilitate the successful presentation of portfolio companies to a broad range of investors, including venture capitalists and corporate investors.

Barry Heninger

Managing Partner, Real Estate Access Fund

Nathan McDonald

Chief Executive Officer & Managing Partner

105 past transactions

Levered Learning

Venture Round in 2021
Levered Learning is an instructional system focused on enhancing mathematical education for students in grades 3 to 5. Founded in 2017 and based in Soquel, California, the company offers a web-based platform that combines whole-class discussions, collaborative pencil-and-paper exercises, and self-paced online lessons. This system is designed to support both classroom and distance learning, helping teachers address learning gaps while promoting student growth in mathematics. By integrating various teaching methods, Levered Learning aims to improve educational outcomes for elementary students.

Tend Health

Venture Round in 2021
MicrobiomX, Inc. develops fecal microbiota transplant solutions. It offers clinicians a non-invasive way to restore their patient’s personalized healthy intestinal microbiome. The company was incorporated in 2020 and is based in Seattle, Washington.

Pattern Computer

Venture Round in 2021
Pattern Computer, Inc. is a pattern discovery company that specializes in uncovering insights from complex datasets. Founded in 2016 and headquartered in Friday Harbor, Washington, the company develops a unique pattern discovery system and platform technology aimed at generating valuable hypotheses and insights for both research and business applications. Its innovative approach enables the identification of novel patterns that conventional techniques often overlook, even when using advanced computing resources. The company's platform is particularly effective in medical research, with applications in breast cancer prognostics and the analysis of microbiome and human gut disorders. Through its hypothesis-generating engine, Pattern Computer seeks to address some of the most challenging problems in the medical field.

Healionics

Venture Round in 2021
Healionics Corporation develops and manufactures synthetic biomaterials and implantable medical devices. It offers STARport HDTM, an implantable device that allows needle-free bloodstream access for hemodialysis treatment; STARgraft, a synthetic vascular graft for maintaining blood flow; and sphere templated angiogenic regeneration technology that provides 3D biomaterial scaffolds that enhance the bio-integration and function of medical implants. The company also provides solutions for implant applications, including the ability to impart resistance to infection and fibrous encapsulation, and promotion of angiogenesis. Healionics Corporation was founded in 2007 and is based in Seattle, Washington.

Seneca Therapeutics

Venture Round in 2021
Seneca Therapeutics, Inc. engages in development of oncolytic immunotherapeutic and derivatives for the treatment of various cancers. It offers Seneca Valley Virus (SVV), an oncolytic virus that eliminates tumor cells in which it can replicate. The company’s SVV is available as cancer therapeutics, cancer vaccines, and vaccines for infectious diseases. Seneca Therapeutics, Inc. was incorporated in 2018 and is headquartered in Blue Bell, Pennsylvania.

EternaTear

Series A in 2020
EternaTear, Inc. develops artificial tear solution that provides lubrication for dry eyes. It provides EternaTear, an artificial tear for people who suffer from the progressive dry eye. It provides therapy for dry eye using a novel and proprietary mechanism to supplement all three layers of the tear film and bind them together on the ocular surface. The company was incorporated in 2018 and is based in Raleigh, North Carolina.

Steelhead Composites

Venture Round in 2020
Steelhead Composites is an engineering and manufacturing company with full service, in house design, testing, prototyping and production of composite pressure vessels, hydrogen storage, seamless metal cylinders, composite structures and pressurant tanks. The advanced manufacturing process, fully digital shop floor, superb quality systems and design capabilities allow Steelhead to compete in niche hydraulic applications, aerospace applications and in the design and manufacturing of hydrogen storage options for fuel cells and vessels for containing compressed gasses.

LumiThera

Series C in 2020
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing treatment solutions aimed at improving visual function and preventing vision loss due to debilitating eye diseases. The company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda system, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. Founded in 2013, the company is dedicated to halting or slowing the progression of blinding diseases and enhancing the quality of life for patients affected by these conditions.

Your Fare

Convertible Note in 2020
Your Fare is an online ordering management platform for restaurants that allows its users to track sales on one dashboard. It also allows restaurateurs to replace their online ordering tablets. It helps manage all 3rd party delivery services in a way that works best for its user. It was built for restaurant operators, by restaurant operators. It was founded in 2015 and is headquartered in Austin, Texas.

HaptX

Series A in 2019
HaptX® makes technology that simulates touch sensation with unprecedented realism. HaptX Gloves enable natural interaction and realistic haptic feedback in virtual reality for the first time. Built with patented microfluidic technology, HaptX Gloves feature 130 points of touch feedback, apply 4 lbs. of resistive force feedback per finger, and track hand motions with sub-millimeter precision. Founded by Jake Rubin and Dr. Bob Crockett, HaptX has 35 employees, with offices in Seattle, WA and San Luis Obispo, CA.

Embera NeuroTherapeutics

Series B in 2019
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

PittMoss

Series B in 2019
PittMoss LLC manufactures an innovative growing media called PittMoss, which consists of organic additives and recycled paper, catering to commercial greenhouses, nurseries, and home gardeners across the United States. The company also produces PittMoss Prime, a versatile soil amendment that can be combined with compost, existing soil blends, or native soil. Founded in 1994 and based in Ambridge, Pennsylvania, PittMoss focuses on sustainability and environmental responsibility, aiming to enhance soil health and improve gardening outcomes. The company's products reflect extensive research and development in the fields of gardening and soil science, establishing a strong presence in the growing media market.

UnaliWear

Seed Round in 2019
UnaliWear Inc. develops a wearable watch that provides discreet support for falls, medication reminders, and a guard against lost-wandering with ‘guide-me-home’ assistance. The company was incorporated in 2013 and is based in Austin, Texas.

Point of Choice

Venture Round in 2019
Point of Choice LLC develops cloud-based platform that streamlines the purchasing process of school district. It provides k-Purchase, software that ensures vendor product offerings, special pricing and promotions reach the right people in each school districts . The company was incorporated in 2015 and is based in Fairfield, Iowa.

Astarte Medical

Series A in 2019
Astarte Medical Partners, Inc. develops a software that provides a universal view of clinical data in real time to assess the state of the preterm infant’s gut health to make more informed decisions. The product enables NICU clinical care teams to standardize and streamline the practice of feeding. Astarte Medical Partners, Inc. was incorporated in 2016 and is based in Yardley, Pennsylvania.

Stor and Deliver

Venture Round in 2019
Stor and Deliver was founded to free you from the hassle of loading, hauling, and moving into storage. They provide full-service, concierge storage with a pickup at your door and on-demand return delivery for the cost of a traditional self-storage unit.

Kokopelli Outdoor

Venture Round in 2019
Kokopelli Outdoor, Inc. manufactures packrafts and related gear. The company also organizes packrafting courses and events. It also engages in the online retail of packrafts. The company was founded in 2014 and is based in Denver, Colorado.

Turn Technologies

Venture Round in 2019
Turn Technologies, Inc. specializes in developing an online application designed for managing the workforce, particularly in the gig economy. Founded in 2016 and headquartered in Chicago, Illinois, the company operates an AI-powered workforce-as-a-service platform that enables businesses to efficiently source, screen, and retain 1099 workers. Its integrated platform is tailored to meet the demands of contingent workforce management, offering features such as mobile-friendly services, seamless API and HR integration, and robust candidate profiles. The platform allows companies to quickly identify suitable applicants, verify their credentials, and activate them for work within hours. Additionally, Turn Technologies provides built-in compliance tools to ensure that businesses can onboard workers seamlessly and scale their operations effectively.

Atrin Pharmaceuticals

Venture Round in 2019
Atrin Pharmaceuticals LLC is a biopharmaceutical company based in Doylestown, Pennsylvania, focused on the discovery and development of innovative cancer treatments. Founded in 2011, the company specializes in proprietary medications, including ATRN-502, a p53 activator, and ATRN-507, a dual ligand that selectively targets cancer cells. Atrin's advanced research is centered on developing a new class of compounds that act as specific inhibitors of ATR, a crucial mediator in DNA repair. The company utilizes its proprietary screening platform, Atrize, which enables high-throughput evaluation of drug candidates and personalized medicine approaches. This platform allows for the rapid identification of compounds that effectively inhibit cancer cell viability while minimizing effects on healthy cells, thus advancing the potential for more effective cancer therapies.

InReality

Venture Round in 2018
InReality is a solution-as-a-service company that helps brands and retailers drive conversion and optimize in-store investments. Brands and retailers use our IoT-based customer experience solutions to drive in-store conversion of shoppers to sales. Companies leverage our platform to maximize the consumer journey across stores, categories, displays or merchandise. Through real-time analytics and responsive technology combined with insight, design and delivery services, we ensure success by optimizing return on marketing spend.

Virion Therapeutics

Series A in 2018
Virion Therapeutics, LLC, a biotechnology company, develops immune-based treatments for virally-associated cancers and chronic viral infections. It offers ChiVax and ChiVax-gD vaccines to induce potent and sustained T cell-mediated immune responses against transformed and infected cells. Virion Therapeutics, LLC was incorporated in 2018 and is based in Newark, Delaware.

SageMedic

Venture Round in 2018
SageMedic Corporation develops SAGE Direct Test, a medicine for the treatment of cancer patients. Its technology uses a biopsy of patient’s live cancer tissue to create biologically similar 3D micro-tumors in lab. The company was incorporated in 2017 and is based in Redwood City, California.

Toma Biosciences

Series C in 2018
TOMA Biosciences, Inc. develops reagent kits that enable laboratories and researchers to uncover genomic changes in tumors. The company offers TOMA OS-Seq, an oncology-focused gene analysis solution. It serves laboratories, hospital systems, and research institutions worldwide. The company was incorporated in 2011 and is based in Foster City, California.

RealKey

Funding Round in 2018
RealKey, Inc., established in 2015 and located in San Francisco, California, specializes in digital mortgage technologies aimed at enhancing the mortgage processing experience for both bank and non-bank mortgage loan originators (MLOs). The company's RealKey Digital Mortgage Platform addresses the inefficiencies of traditional mortgage systems by automating document collection, data review, and secure communication among all parties involved in the mortgage process. This innovation significantly reduces the loan processing cycle by approximately 50%, allowing MLOs to close loans more rapidly and efficiently. As a result, RealKey empowers MLOs to scale their operations in response to the increasing demand for mortgage applications, particularly during periods of heightened lending activity. The platform integrates seamlessly with existing point of sale and loan origination systems, providing a comprehensive digital mortgage processing experience for lenders, brokers, and their clients.

PittMoss

Seed Round in 2018
PittMoss LLC manufactures an innovative growing media called PittMoss, which consists of organic additives and recycled paper, catering to commercial greenhouses, nurseries, and home gardeners across the United States. The company also produces PittMoss Prime, a versatile soil amendment that can be combined with compost, existing soil blends, or native soil. Founded in 1994 and based in Ambridge, Pennsylvania, PittMoss focuses on sustainability and environmental responsibility, aiming to enhance soil health and improve gardening outcomes. The company's products reflect extensive research and development in the fields of gardening and soil science, establishing a strong presence in the growing media market.

Beta Hatch

Seed Round in 2018
Beta Hatch grows insect protein for animal feed. Nutrient balanced fertilizer is a sterile by-product of their process. Beta Hatch knows bugs better than anyone- they use their expertise in entomology to grow the most efficient and nutritious insects. They are currently farming mealworms from their urban farm in Seattle. They believe in changing food systems. Their goal is to develop the technology and knowledge that will make insects the next commodity crop.

OtoNexus Medical Technologies

Private Equity Round in 2017
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.

Alpin

Angel Round in 2017
Alpin, Inc. develops a cloud identity management platform that allows users and companies to find and manage their cloud software. It also enables the users to discover cloud software, manage costs and renewals, security and compliance, and automates workflow. Alpin, Inc. was formerly known as Logrr, Inc. The company was incorporated in 2015 and is based in Boulder, Colorado. As of October 25, 2019, Alpin, Inc. operates as a subsidiary of Coreview.

SHM Control

Seed Round in 2017
SHM Controls Inc. specializes in designing touch-screen devices for managing boilers and hot-water tanks in various settings, including residential and commercial buildings, schools, and hospitals. Established in 2011 and headquartered in Vancouver, Canada, the company developed the SHM Controller™ to address the rising gas expenses faced by apartment buildings. The device offers remote control of heating systems, allowing users to monitor gas consumption via on-device displays, web platforms, and mobile applications. Additionally, it provides email and text alerts, enhancing operational efficiency and cost management. The SHM Controller™ is a collaborative innovation that combines expertise from real estate, computer engineering, and HVAC technicians to meet market demands effectively.

Blaze Bioscience

Series B in 2017
Blaze Bioscience, Inc., a biotechnology company, develops tumor paint products and Optide-based guided therapeutics. It offers BLZ-100, a tumor paint product candidate for cancer surgery in various solid tumor types that includes an optide, which binds and internalizes into cancer cells, and a fluorescent dye that emits light in the near-infrared range. The company’s products are used in brain, breast, prostate, lung, colorectal, skin, and sarcomas cancer applications. Blaze Bioscience, Inc. was founded in 2010 and is based in Seattle, Washington.

PainQx

Venture Round in 2017
PainQx is a diagnostic/software company that has developed a next generation approach to objectively measure pain in humans. The PainQx platform achieves this by assessing neural activity from a patient’s brain and processing and decoding the data through proprietary algorithms. The output is a scaled pain and neurological side effects biomarker that is directly correlated to a patient’s pain state. The PainQx system is currently being used as a clinical assessment tool by companies using pain as a primary or secondary clinical end point to measure their drug’s and/or device’s efficacy.

Waggit

Funding Round in 2017
Waggit is a comprehensive application, which they tailored to fit all your needs, and to make the process of following your dog's health and life super easy and convenient.

Art Analysis & Research

Series A in 2017
Art Analysis & Research Limited provides technical investigations of paintings. It offers services, such as pigment and binding media analysis; ultra-high resolution digital imaging; specialist interpretation of technical imaging; technical research studies for establishing attribution, condition, and dating; forgery detection and assistance in attribution studies; legal expert witness provision; and dendrochronology, paper history, wood identification, isotope analysis, radiocarbon, and bomb curve dating. The company was incorporated in 2009 and is headquartered in Kingston Upon Thames, United Kingdom.

Touchjet

Venture Round in 2017
Touchjet Pte. Ltd. manufactures interactive android projectors with touch interface and wireless streaming. It offers Touchjet Pond Projector, which turns any flat surface, such as wall, ceiling, and floor, into a touchscreen. It also provides digital stylus which is an infrared emitter in the form of a pen. Touchjet Pte. Ltd. was founded in 2013 and is based in Singapore with an additional office in San Francisco, California.

Zive

Seed Round in 2017
Zive, Inc., a consumer software company, develops 'Kiwi for Gmail', an email desktop application for Mac and Windows users. Kiwi for Gmail is up to 2.0, which comes with a new toolbar and allows users to multitask. The application turns G Suite applications like docs and slides, into Windows desktop applications. The company was founded in 2013 and is headquartered in New York, New York.

Fairway America

Venture Round in 2017
Fairway America is a private equity and advisory firm based in Portland, Oregon, that focuses on commercial real estate asset-based investments within the middle market across the United States. Established in 1992, the firm aims to provide investors with access to the fragmented and opportunity-rich middle market by partnering with select real estate entrepreneurs. Fairway America offers essential operational support and capital to its Sponsor Partners, enabling them to develop and manage investments effectively. The firm specializes in delivering alternative real estate investment products to sophisticated investors, emphasizing sectors such as retail and self-storage. Through its strategic partnerships, Fairway America facilitates investment opportunities that may otherwise be difficult to access.

Phytelligence

Convertible Note in 2016
Phytelligence is a product-focused technology company that develops and provides smart plants and solutions to growers, nurseries, and horticultural experts. It provides custom genetic analysis services that assess the similarity or dissimilarity of closely related samples. The company provides plants free of diseases, viruses, and pests. Its portfolio includes the Geneva series, Gisela series, and Krymsk series of rootstocks. Phytelligence was founded in 2012 by Amit Dhingra, and it is based in Pullman, Washington.

Picmonic

Series A in 2016
Picmonic Inc. operates an audiovisual learning platform designed to enhance memory retention and improve exam performance for students in various fields, particularly nursing and medicine. The platform transforms traditional textbook information into engaging visual stories, known as Picmonics, which utilize humor and memorable graphics to facilitate effective studying. Covering a wide range of subjects including pharmacology, microbiology, and anatomy, Picmonic also offers tools for users to learn, review, and quiz themselves, making the study process interactive and personalized. Founded in 2011 and based in Tempe, Arizona, Picmonic aims to foster a collaborative educational community where learners can create, share, and discover content that enhances academic and professional outcomes.

Lungpacer Medical

Angel Round in 2016
Lungpacer Medical is developing a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle The objective of the company is to develop and commercialize a novel therapeutic solution that addresses the significant health and cost issues associated with mechanical ventilation of critically ill patients in hospital Intensive Care Units (ICU). It is designed to activate the diaphragm using a temporary, minimally invasive, transvascular nerve stimulation approach that is expected to save many lives, improve surviving patient outcomes and greatly reduce hospital care costs. In addition, the paced diaphragm is expected to restore negative pressure ventilation, thereby potentially providing a more physiological respiratory pattern and reducing the levels of positive pressure ventilation and its harmful effects on the lungs. Lung Pacer was founded in 2009 and is headquartered in Vancouver, British Columbia, Canada.

Bouxtie

Seed Round in 2016
Bouxtie [pronounced bow-tie] is transforming the way people give gifts and connect. With the Bouxtie application select from hundreds of top retail brands and instantly send a digital gift card right from your phone.

Curb

Convertible Note in 2016
Curb, Inc. is a technology company based in Austin, Texas, founded in 2012. It specializes in energy engagement software and home energy management solutions. Curb develops a mobile application and web interface that enables users to monitor their electricity usage, uncover home energy trends, and identify appliances that contribute significantly to energy costs. The platform also offers tips for energy savings and provides safety alerts related to electricity use. By consolidating these features in a single product, Curb empowers homeowners to take control of their energy consumption and manage their electricity bills more effectively.

Vispera

Seed Round in 2016
Vispera Information Technologies, founded in 2014 and headquartered in Istanbul, Turkey, specializes in image recognition and analytics tailored for the retail sector. The company offers proprietary technology that provides retailers and suppliers with critical insights to enhance performance at points of sale. Vispera's solutions enable clients to monitor in-store execution and make necessary adjustments through real-time data analysis. Key metrics offered by the platform include on-shelf availability, planogram compliance, and pricing accuracy. These services address significant issues within the retail industry, such as the annual losses attributed to poor on-shelf availability. By leveraging advanced image recognition technology, Vispera aims to transform retail operations, moving beyond being a simple vendor to becoming a comprehensive retail data analytics provider. The company's commitment to high accuracy and customer satisfaction has resulted in a growing client base, as competitors' clients increasingly turn to Vispera for their needs in retail execution and analytics.

Textile-Based Delivery

Venture Round in 2016
Textile-Based Delivery, Inc., doing business as Nufabrx, develops and manufactures medication embedded fabrics. It offers bamboo pillowcase that is embedded with tea tree oil and lavender, which is released while in-sleep. The company provides its products for use in headbands, wristbands, socks, shirts, shorts, underwear, shoes, leggings, athletic shirts, athletic shorts, undergarments, head/wrist bands, hats, and swimwear. Textile-Based Delivery, Inc. was formerly known as Textile-Based Delivery Merger, Inc. The company was founded in 2011 and is based in Seattle, Washington with an additional office in Minneapolis, Minnesota.

UnaliWear

Series A in 2016
UnaliWear Inc. develops a wearable watch that provides discreet support for falls, medication reminders, and a guard against lost-wandering with ‘guide-me-home’ assistance. The company was incorporated in 2013 and is based in Austin, Texas.

Safe H2O

Seed Round in 2016
Safe H2O operates as a water bio detection company that provides pathogen test systems and data services. It engages in assisting water managers and water treatment service providers in reducing fatalities and illnesses related to waterborne pathogens and assuring the sustainability of water systems.

Resonance AI

Seed Round in 2016
Resonance AI specializes in the fields of artificial intelligence, analytics, and video streaming. Using advanced machine learning available, Resonance AI’s unmatched efficiency and accuracy enables quick decisions about content and talent grounded in real performance data. It was founded in 2013 and headquartered in Seattle, Washington.

Sisu Global Health

Seed Round in 2016
Sisu Global Health provides clinically proven, patented, high margin devices, starting with Hemafuse, a highly effective alternative to donor blood. With a simple push and pull of a handle, the device transfers blood from where it is pooled in internal bleeding to a blood bag: blood is salvaged and immediately re-transfused. Sisu achieved regulatory approval in Ghana and Kenya and Hemafuse and signed two distribution contracts. Founded in 2014 by Carolyn Yarina, Gillian Henker, and Katie Kirsch, Sisu Global Health is headquartered in Baltimore, Maryland.

Cone & Steiner

Venture Round in 2016
Cone & Steiner is a one-stop shop brimming indoors and out with fresh flowers and produce, dry goods, ice cream, and a curated selection of prepared foods. It features a unique twist on the corner store it features specialty, local, and staple goods, as well as a robust assortment of craft beers and fine wines.

Embera NeuroTherapeutics

Venture Round in 2016
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Reelsonar

Venture Round in 2016
ReelSonar, Inc. designs and develops a mobile application through which the location of fish underneath the water can be determined. It offers iBobber, a software and hardware fish finding product that uses sonar to locate fish down to 135’ in the water, while the application enables users to GPS tag favorite hotspots, map waterbed contours, and measures water temperature. Its iBobber works with smartphones and tablets. The company offers its products through retailers, distributors, and online in the United States, Canada, Europe, Asia, and internationally. ReelSonar, Inc. was incorporated in 2012 and is based in Seattle, Washington.

Precision Image Analysis

Venture Round in 2016
Precision Image Analysis (PIA) provides an innovative remote image post-processing analysis service for use in diagnostic medical studies, including CT and MRI. HIPAA compliant IT architecture enables to upload images, monitor, track, and retrieve analyses remotely. Precision Image Analysis expertly-trained analysts deliver results in as few as two hours. It offers CT and MRI post-processing services to the healthcare and research communities with specific expertise in Cardiac, Vascular and Neuro. Migrating cardiovascular image analysis tasks to PIA means that you don’t have to worry about the schedule, time, or resource bottlenecks. It can easily and inexpensively scale up and down with surges in image analysis volume. No need to hire additional staff, invest in software training, or spend on unnecessary new technology. PIA Medical was founded in 2012 and is headquartered in Kirkland, Washington, United States.
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Analyze

Venture Round in 2016
Analyze Corporation specializes in big data analytics and cybersecurity solutions, aiming to enhance organizational performance and customer privacy. Founded in 2013 and headquartered in Fairfax, Virginia, the company offers a suite of products designed for various industries. These include Clientell, a cloud-based SaaS tool for targeted marketing, and Donor Impact, which assists non-profit organizations in identifying potential donors. Additionally, Analyze develops Chi-Square, an open-source Linux distribution project, and Pin Drop PRO, a solution focused on retail location analytics. The company’s self-service platform enables clients to transform customer data into actionable insights, appending extensive data characteristics to enhance market segmentation and optimize return on investment.

First Light Diagnostics

Venture Round in 2016
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.

iHealthHome

Venture Round in 2016
iHealthHome, LLC specializes in providing an in-home monitoring and communication system tailored for professional caregivers. Founded in 2009 and based in Honolulu, Hawaii, the company offers a comprehensive data collection device that integrates with web-based software, allowing for seamless communication and care management. Its flagship product, the iHealthNavigator, serves as a care management application designed to equip clinical teams with essential tools to streamline daily tasks and coordinate client care effectively. Targeting home care agencies, complex care coordinators, residential care homes, senior living communities, and family caregivers, iHealthHome aims to enhance the quality, efficiency, and satisfaction of at-home healthcare services. The company operates as a subsidiary of Ho'okele Health Innovations, LLC.

Indow

Venture Round in 2016
Indow Windows provides people with comfort and quiet while helping them achieve financial and environmental harmony. Indow Windows are window inserts that press into place on the inside of existing window frames with no nails, screws, or adhesives. It gives all of the energy-saving benefits of double pane windows but has the bonus feature of reducing the noise coming in from outside by 50% or more. An Indow Window is made of a sheet of acrylic glazing edged with our patented Compression Tube. The simple yet elegant design creates a very low profile when installed so that the product disappears and its own Home's beauty shines through. Indow Windows was founded by CEO, Sam Pardue with the mission of maximizing carbon reductions and customer comfort and savings.

Operative Experience

Venture Round in 2016
Operative Experience Inc. designs and manufactures advanced simulation-based training systems for surgical and emergency medical services applications on a global scale. The company offers a range of training solutions, including the emergency obstetrics surgical training system, which features simulators for various procedures such as fetal extraction and emergency hysterectomy. Operative Experience also provides emergency cranial and thoracotomy surgery solutions, along with the MasCal Trauma Training System, which consists of ruggedized combat trauma simulators designed to prepare users for tactical combat casualty care. Additionally, the company’s offerings include comprehensive training for combat casualty care procedures, addressing critical interventions such as hemorrhage control and amputation techniques. Established in 2008 and headquartered in North East, Maryland, Operative Experience is committed to enhancing surgical training effectiveness while aiming to reduce mortality rates in both combat and civilian contexts, as well as providing support to regions with limited medical resources.

TranscribeMe

Venture Round in 2016
TranscribeMe Inc. develops a mobile audio transcription platform that converts audio and video content into searchable and shareable text. Founded in 2011, the company is headquartered in San Francisco, California, and utilizes proprietary micro-tasking technology to deliver high-quality transcriptions, including speaker identification and time coding. Its services cater to various sectors, including medical, market research, education, and corporate environments, enabling clients such as medical professionals, conference organizers, writers, podcasters, and academics to analyze and monetize their audio content. By processing audio in parallel, TranscribeMe effectively handles complex recordings with multiple speakers and overlapping conversations, ensuring accurate and efficient transcription.

Perkville

Venture Round in 2016
Perkville is a leading retention and referral solution for the health, fitness, salon, spa, and retail industries. Their rewards program integrates directly with POS or scheduling systems and can be custom-tailored for every business. Featured in businesses around the world, the Perkville system can drive referrals, reward clients for return visits and make purchases, and even generate social media posts. It was founded in 2010 and is headquartered in Oakland, California.

Blaze Bioscience

Venture Round in 2016
Blaze Bioscience, Inc., a biotechnology company, develops tumor paint products and Optide-based guided therapeutics. It offers BLZ-100, a tumor paint product candidate for cancer surgery in various solid tumor types that includes an optide, which binds and internalizes into cancer cells, and a fluorescent dye that emits light in the near-infrared range. The company’s products are used in brain, breast, prostate, lung, colorectal, skin, and sarcomas cancer applications. Blaze Bioscience, Inc. was founded in 2010 and is based in Seattle, Washington.

Viakoo

Venture Round in 2016
Viakoo, Inc. offers a software-as-a-service (SaaS) application that provides advisories about problems in video network infrastructure. Its products include Viakoo Preemptive, Viakoo Predictive, and Viakoo Predictive OP, which enables users to discover, map, and instrument their video network; and provides performance trending information of video surveillance infrastructure, the dashboard status, bulletins, summary reports, real-time detection, remote alerting, and a troubleshooting database. The company also provides customer support and diagnostics, troubleshooting assistance, and professional services. Viakoo, Inc. was incorporated in 2013 and is based in Mountain View, California.

LumiThera

Venture Round in 2016
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing treatment solutions aimed at improving visual function and preventing vision loss due to debilitating eye diseases. The company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda system, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. Founded in 2013, the company is dedicated to halting or slowing the progression of blinding diseases and enhancing the quality of life for patients affected by these conditions.

Savara

Series C in 2016
Savara Inc. is a biopharmaceutical company based in Austin, Texas, specializing in rare respiratory diseases. Its primary product candidate, Molgradex, is an inhaled granulocyte-macrophage colony-stimulating factor currently in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Additionally, Molgradex is being evaluated in Phase IIa trials for nontuberculous mycobacterial (NTM) lung infections and cystic fibrosis patients with chronic NTM infections. Savara is also developing AeroVanc, an inhaled vancomycin, which is in Phase III trials for treating methicillin-resistant Staphylococcus aureus (MRSA) lung infections in cystic fibrosis patients. The company aims to expand its pipeline through strategic partnerships and product acquisitions, including a recent acquisition of a combination antibiotic that targets drug-resistant pathogens. Savara's management team has extensive experience in orphan drug development and is focused on addressing unmet medical needs in the field of pulmonary medicine.

Linqto

Seed Round in 2016
Linqto is a financial technology company that facilitates liquidity in private securities markets, enabling founders, venture capitalists, and employees to access early returns without waiting for an initial public offering or trade sale. By allowing companies to remain private for longer periods while still providing ongoing liquidity, Linqto supports a more flexible investment environment. The platform connects accredited investors with a diverse range of private companies across various sectors, helping them identify firms that are well-positioned for successful IPOs. Through its technology-driven approach, Linqto aims to democratize access to private investments, similar to how traditional brokerage firms have made public equity trading more accessible.

LumiThera

Venture Round in 2016
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing treatment solutions aimed at improving visual function and preventing vision loss due to debilitating eye diseases. The company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda system, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. Founded in 2013, the company is dedicated to halting or slowing the progression of blinding diseases and enhancing the quality of life for patients affected by these conditions.

Monitor Mask

Venture Round in 2016
Monitor Mask Inc. is a Seattle-based medical device company that specializes in manufacturing and selling face mask solutions designed for CO2 sampling in sidestream capnography, particularly during sedation anesthesia. Founded in 2012, the company primarily serves hospitals and ambulatory surgery centers, catering to various medical environments such as operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. The initial product, the M1 Capnography Mask, inspired the development of the CapnoVue face mask series, which aims to enhance patient safety and streamline clinical workflows. As of May 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

Embera NeuroTherapeutics

Venture Round in 2016
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Bouxtie

Venture Round in 2016
Bouxtie [pronounced bow-tie] is transforming the way people give gifts and connect. With the Bouxtie application select from hundreds of top retail brands and instantly send a digital gift card right from your phone.

Tether Technologies

Series A in 2016
Tether Technologies, Inc. provides a preemptive key loss technology that helps people and businesses maintain security while eliminating key loss events and costly repercussions. It offers ekt (electronic key tether), a preemptive key loss solution that locates the keys before they are lost, as well as keeps the keys within a 15-step radius of the user. The company also provides support services. It serves security, janitorial, property and facility management, hospitality, health care, and law enforcement and corrections markets. The company was founded in 2010 and is based in Seattle, Washington.

WattIQ

Venture Round in 2016
IBIS Networks, Inc. provides energy management solutions for the enterprise sector. The company offers Ibis Plug Load Management System that include InteliSockets that are the energy meters and control points, which plugs in between equipment and the wall sockets; InteliGateways that handles various communications between InteliSockets and InteliNetwork; and InteliNetwork, a cloud-based reporting and control dashboard that provides advanced data visualization, scheduling, and configuration capabilities. It serves schools and higher education, hospitality, and office building markets. The company was incorporated in 2013 and is based in Honolulu, Hawaii with additional offices in California and Washington.

Precision Image Analysis

Venture Round in 2016
Precision Image Analysis (PIA) provides an innovative remote image post-processing analysis service for use in diagnostic medical studies, including CT and MRI. HIPAA compliant IT architecture enables to upload images, monitor, track, and retrieve analyses remotely. Precision Image Analysis expertly-trained analysts deliver results in as few as two hours. It offers CT and MRI post-processing services to the healthcare and research communities with specific expertise in Cardiac, Vascular and Neuro. Migrating cardiovascular image analysis tasks to PIA means that you don’t have to worry about the schedule, time, or resource bottlenecks. It can easily and inexpensively scale up and down with surges in image analysis volume. No need to hire additional staff, invest in software training, or spend on unnecessary new technology. PIA Medical was founded in 2012 and is headquartered in Kirkland, Washington, United States.

KPI Therapeutics

Venture Round in 2015
KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors. The company believes that as an industry we can do better than develop just 20 to 30 new drugs per year. Our vision of KPI is to speed the progression of promising drug candidates through the critical translational stage of development and work with commercialization partners who have a strong commitment to improving access to important new medicines. It was founded in 2013 and headquartered in Seattle, Washington.

iHealthHome

Venture Round in 2015
iHealthHome, LLC specializes in providing an in-home monitoring and communication system tailored for professional caregivers. Founded in 2009 and based in Honolulu, Hawaii, the company offers a comprehensive data collection device that integrates with web-based software, allowing for seamless communication and care management. Its flagship product, the iHealthNavigator, serves as a care management application designed to equip clinical teams with essential tools to streamline daily tasks and coordinate client care effectively. Targeting home care agencies, complex care coordinators, residential care homes, senior living communities, and family caregivers, iHealthHome aims to enhance the quality, efficiency, and satisfaction of at-home healthcare services. The company operates as a subsidiary of Ho'okele Health Innovations, LLC.

Bouxtie

Seed Round in 2015
Bouxtie [pronounced bow-tie] is transforming the way people give gifts and connect. With the Bouxtie application select from hundreds of top retail brands and instantly send a digital gift card right from your phone.

Indow

Series B in 2015
Indow Windows provides people with comfort and quiet while helping them achieve financial and environmental harmony. Indow Windows are window inserts that press into place on the inside of existing window frames with no nails, screws, or adhesives. It gives all of the energy-saving benefits of double pane windows but has the bonus feature of reducing the noise coming in from outside by 50% or more. An Indow Window is made of a sheet of acrylic glazing edged with our patented Compression Tube. The simple yet elegant design creates a very low profile when installed so that the product disappears and its own Home's beauty shines through. Indow Windows was founded by CEO, Sam Pardue with the mission of maximizing carbon reductions and customer comfort and savings.

Abom

Convertible Note in 2015
Abom, Inc. is a company based in Portland, Oregon, founded in 2014, specializing in the design and development of snow goggles featuring active anti-fog technology. The innovative goggles utilize a metal film embedded in the lens that heats up to prevent fogging, enhancing visibility and performance for users in snowy conditions. Abom brings together a team of inventors, scientists, and designers dedicated to creating advanced gear that addresses common challenges faced by outdoor enthusiasts, thereby improving their overall experience.

Tilting Motor Works

Series A in 2015
Tilting Motor Works' patented leaning front trike conversion gives motorcycle riders 3-wheel stability with a 2-wheel ride. Because it leans into the turns like the original motorcycle, the handling and performance is superior to that of any 3-wheel alternative. It lets veteran riders stay connected with their friends on the road for years longer. It gives newer riders the confidence to take command of a big Harley®. Performance enthusiasts like the high-speed cornering that comes with improved traction and braking.

Monitor Mask

Series A in 2015
Monitor Mask Inc. is a Seattle-based medical device company that specializes in manufacturing and selling face mask solutions designed for CO2 sampling in sidestream capnography, particularly during sedation anesthesia. Founded in 2012, the company primarily serves hospitals and ambulatory surgery centers, catering to various medical environments such as operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. The initial product, the M1 Capnography Mask, inspired the development of the CapnoVue face mask series, which aims to enhance patient safety and streamline clinical workflows. As of May 2019, Monitor Mask operates as a subsidiary of Salter Labs Inc.

LumiThera

Series A in 2015
LumiThera, Inc. is a medical device company based in Poulsbo, Washington, that specializes in developing treatment solutions aimed at improving visual function and preventing vision loss due to debilitating eye diseases. The company focuses on photobiomodulation (PBM) therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular conditions. LumiThera's flagship product, The Valeda system, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular disorders. Founded in 2013, the company is dedicated to halting or slowing the progression of blinding diseases and enhancing the quality of life for patients affected by these conditions.

First Light Diagnostics

Series A in 2015
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.

Precision Image Analysis

Series B in 2015
Precision Image Analysis (PIA) provides an innovative remote image post-processing analysis service for use in diagnostic medical studies, including CT and MRI. HIPAA compliant IT architecture enables to upload images, monitor, track, and retrieve analyses remotely. Precision Image Analysis expertly-trained analysts deliver results in as few as two hours. It offers CT and MRI post-processing services to the healthcare and research communities with specific expertise in Cardiac, Vascular and Neuro. Migrating cardiovascular image analysis tasks to PIA means that you don’t have to worry about the schedule, time, or resource bottlenecks. It can easily and inexpensively scale up and down with surges in image analysis volume. No need to hire additional staff, invest in software training, or spend on unnecessary new technology. PIA Medical was founded in 2012 and is headquartered in Kirkland, Washington, United States.

Embera NeuroTherapeutics

Venture Round in 2015
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

Acceleration Systems

Venture Round in 2015
Acceleration Systems is led by a core group of business, technology, and marketing professionals. They have extensive experience ranging from startups to Fortune 1000 companies with expertise in Internet technology, software development, and channel partner cultivation. Acceleration Systems is made up of a collection of some of the coolest talent based around the United States – and soon to be world (Muwhahahaha… ::rubbing hands together in an evil fashion::) – that are passionate about producing products and solutions to address the worldwide bandwidth problem. We are currently searching for a private island (preferably one with an active volcano) where we can build our new world headquarters. Let us know if you have any ideas.

Aqueduct Critical Care

Venture Round in 2015
Aqueduct Critical Care addresses the critical care problem of managing inter-cranial pressure. Its working prototypes demonstrate the ability to allow the patient to move, and minimize attention from nursing staff. Aqueduct Critical Care was founded in 2013 and is based in Bothell, Washington.

20/20 Gene Systems

Series A in 2015
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Their headquarters are in the heart of the biotechnology corridor in Rockville, Maryland in close proximity to the National Institutes of Health with which they have extensive collaborations. 20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer. These tests generally fall into three categories: - Personalized Medicine: Their patented platform technology for measuring biomarkers in tumors is highly unique in that it combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. - Early detection of lung cancer: 20/20 is developing a blood test for the early detection of lung cancer. This product will be used for screening smokers and former smokers to pre-select or enrich the patient population to receive annual CT scanning long before the disease becomes symptomatic. - Biological Detection: 20/20 is on the leading edge of developing technologies to help in the detection of biological toxins.

Building Energy

Convertible Note in 2015
Building Energy Inc., headquartered in Portland, Oregon, specializes in developing cloud-based solutions for managing energy disclosure data and compliance in the built environment. The company offers a secure platform that integrates data from various sources, enabling significant improvements in building energy efficiency. Its services include data standardization, management, and compliance solutions tailored for local governments, energy companies, large portfolio managers, and individual building owners. By providing a comprehensive ecosystem of data and applications, Building Energy Inc. aims to enhance decision-making processes and promote better practices within the entire built environment, from design and finance to operation and management. Established in 2012, the company is committed to fostering a trusted network of building data to drive improved outcomes for its clients.

OtoSense

Series A in 2015
OtoSense, Inc., an infrastructure software company, develops deep-learning based sound recognition software platform that enables enterprise customers to build value through sound intelligence. This software platform turns any machine sounds and vibrations into actionable meaning at the edge. Otosense provides an intuitive interface which enables the system to learn from humans, edge sound detection that runs on standard edge devices which are connected to scalable back-end cloud software. The company also develops a mobile application that translates sounds into visual and tactile alerts. Its application recognizes doorbell, alarm, telephone, and other audio alerts. In addition, the company sells acoustic monitoring evaluation kits online. Its products are used in military and civil applications ranging from elderly monitoring to battlefield real time threat identification. OtoSense, Inc. was founded in 2013 and is based in Palo Alto, California. As of April 30, 2018, OtoSense, Inc. operates as a subsidiary of Analog Devices, Inc.

Safe H2O

Seed Round in 2015
Safe H2O operates as a water bio detection company that provides pathogen test systems and data services. It engages in assisting water managers and water treatment service providers in reducing fatalities and illnesses related to waterborne pathogens and assuring the sustainability of water systems.

Crowd Mics

Seed Round in 2015
Crowd Mics LLC, founded in 2014 and based in Mesa, Arizona, has developed a mobile application that enhances audience interaction during live events. The app transforms audience members' iOS and Android devices into wireless microphones, allowing them to speak directly into their phones to be heard over the sound system. In addition to this innovative feature, Crowd Mics offers text commenting and live polling capabilities, which facilitate increased engagement and enable participants to express their viewpoints effectively. The application aims to empower audiences, making them active contributors in various event settings.

OtoNexus Medical Technologies

Private Equity Round in 2015
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of ultrasound medical devices for diagnosing middle ear infections, known as otitis media, in both children and adults. The company's innovative hand-held device enables clinicians to quickly and accurately distinguish between viral and bacterial infections, facilitating appropriate treatment decisions regarding antibiotic use. Utilizing ultrasound technology in a novel manner, the device offers rapid diagnostic results in seconds, making it user-friendly for both physicians and non-physician healthcare providers. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies aims to improve the efficiency and accuracy of middle ear infection diagnosis.

Social Standards

Seed Round in 2015
Social Standards, Inc. develops market research tools to discover and deliver actionable business insights with authentic analysis of social data. Its tool provide consumer voice measurement and marketing insights for beverage alcohol, beauty, personal care, food and beverage, quick serve restaurants, and other industries. Social Standards, Inc. was formerly known as BarTrendr, Inc. and changed its name to Social Standards, Inc., in July 2016. The Company was incorporated in 2011 and is based in Oakland, California

Abom

Series A in 2015
Abom, Inc. is a company based in Portland, Oregon, founded in 2014, specializing in the design and development of snow goggles featuring active anti-fog technology. The innovative goggles utilize a metal film embedded in the lens that heats up to prevent fogging, enhancing visibility and performance for users in snowy conditions. Abom brings together a team of inventors, scientists, and designers dedicated to creating advanced gear that addresses common challenges faced by outdoor enthusiasts, thereby improving their overall experience.

DecisionNext

Seed Round in 2015
DecisionNext, Inc. offers a cloud-based predictive analytics platform tailored for commodities-driven businesses, providing industry-specific insights that assist users in making informed decisions about production and sales locations. The company serves a diverse clientele across sectors such as minerals, agribusiness, fishing, forestry, oil, and gas. Established in 2013 and headquartered in San Francisco, California, with an additional office in Brisbane, Australia, DecisionNext focuses on enhancing end-to-end performance through its solutions, which include commodity price forecasting, purchasing and product mix optimization, capacity optimization, and pricing and promotion strategies. By integrating these optimizations into a cohesive system, DecisionNext aims to deliver significant value to its customers.

Acceleration Systems

Series A in 2015
Acceleration Systems is led by a core group of business, technology, and marketing professionals. They have extensive experience ranging from startups to Fortune 1000 companies with expertise in Internet technology, software development, and channel partner cultivation. Acceleration Systems is made up of a collection of some of the coolest talent based around the United States – and soon to be world (Muwhahahaha… ::rubbing hands together in an evil fashion::) – that are passionate about producing products and solutions to address the worldwide bandwidth problem. We are currently searching for a private island (preferably one with an active volcano) where we can build our new world headquarters. Let us know if you have any ideas.

Embera NeuroTherapeutics

Series A in 2015
Embera NeuroTherapeutics is a development stage pharmaceutical company focused on developing treatments for smoking cessation and other addictions, for which there are a limited range of effective drug therapies or have no approved treatments. Embera is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder.

KiwiCo

Venture Round in 2015
KiwiCo sparks creativity in kids and saves time for busy parents by providing all of the inspiration and materials necessary for hours of imaginative play and learning. With monthly deliveries of activities designed to help kids discover, explore, and create things in the world around them, KiwiCo brings hands-on fun right to the door. It was founded in 2011 and is headquartered in Mountian View, California.

Viakoo

Venture Round in 2015
Viakoo, Inc. offers a software-as-a-service (SaaS) application that provides advisories about problems in video network infrastructure. Its products include Viakoo Preemptive, Viakoo Predictive, and Viakoo Predictive OP, which enables users to discover, map, and instrument their video network; and provides performance trending information of video surveillance infrastructure, the dashboard status, bulletins, summary reports, real-time detection, remote alerting, and a troubleshooting database. The company also provides customer support and diagnostics, troubleshooting assistance, and professional services. Viakoo, Inc. was incorporated in 2013 and is based in Mountain View, California.

KPI Therapeutics

Series A in 2015
KPI Therapeutics is a healthcare company that connects initiative between drug development firms and private investors. The company believes that as an industry we can do better than develop just 20 to 30 new drugs per year. Our vision of KPI is to speed the progression of promising drug candidates through the critical translational stage of development and work with commercialization partners who have a strong commitment to improving access to important new medicines. It was founded in 2013 and headquartered in Seattle, Washington.

Kineta

Series B in 2015
Kineta is a biotechnology company engaging in the discovery and development of antiviral therapies and immune-modulating drugs for the treatment of RNA viruses that include hepatitis C, influenza, West Nile virus, and the common cold. Kineta was founded in 2008 and is based in Seattle, Washington.

Precision Image Analysis

Series B in 2014
Precision Image Analysis (PIA) provides an innovative remote image post-processing analysis service for use in diagnostic medical studies, including CT and MRI. HIPAA compliant IT architecture enables to upload images, monitor, track, and retrieve analyses remotely. Precision Image Analysis expertly-trained analysts deliver results in as few as two hours. It offers CT and MRI post-processing services to the healthcare and research communities with specific expertise in Cardiac, Vascular and Neuro. Migrating cardiovascular image analysis tasks to PIA means that you don’t have to worry about the schedule, time, or resource bottlenecks. It can easily and inexpensively scale up and down with surges in image analysis volume. No need to hire additional staff, invest in software training, or spend on unnecessary new technology. PIA Medical was founded in 2012 and is headquartered in Kirkland, Washington, United States.